Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China

NCT03435406 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-02-19

No results posted yet for this study

Summary

to investigate the prevalence of hepatopulmonary syndrome in cirrhosis patients caused by Hepatitis B in western China

Conditions

  • Hepatopulmonary Syndrome

Sponsors & Collaborators

  • Southwest Hospital, China

    lead OTHER

Principal Investigators

  • Lu K Zhi, PhD · Department of Anesthesiology, Southwest Hospital Third Military Medical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-27
Primary Completion
2018-04-01
Completion
2018-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03435406 on ClinicalTrials.gov